Indoco Remedies gains USFDA approval for Pregabalin capsules

By EP News Bureau On May 22, 2024


Indoco Remedies announced the receipt of final approval from the United States Food and Drug Administration (USFDA for Abbreviated New Drug Application (ANDA) for Pregabalin capsules 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, and 300mg. This is a generic equivalent of the Reference Listed Drug, Lyrica Capsules 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, and 300 mg, of Upjohn US LLC.

This product, Pregabalin capsules, will be manufactured by Indoco Remedies, at their manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa – 403722 in India. Pregabalin is used for Neuropathic pain associated with diabetic peripheral neuropathy and spinal cord injury, Postherpetic neuralgia, and Fibromyalgia.